Elinzanetant is an orally active small-molecule neurokinin/tachykinin NK1 receptor and NK3 receptor antagonist.
It is used for the treatment of hot flashes and sex hormone disorders.
It has been found to relieve hot flashes in postmenopausal women and to dose-dependently suppress luteinizing hormone, estradiol, and progesterone levels in premenopausal women.